ClinConnect ClinConnect Logo
Search / Trial NCT06879002

Comparing IVF/ICSI Cycle Outcomes of Post Ovulation Ovarian Stimulation Protocol with Elonva Without GnRH Antagonist to Follicular Phase Day 2 Stimulation Fixed Day 5 Antagonist Protocol

Launched by ART FERTILITY CLINICS LLC · Mar 11, 2025

Trial Information

Current as of April 23, 2025

Not yet recruiting

Keywords

Progesterone Premature Ovulation Ovarian Stimulation Luteal Stimulation

ClinConnect Summary

No description provided

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Age 18 to 38 years old.
  • Normal Menstrual cycle of 25-35 days.
  • Body Weight 60to90 kg
  • AMH\>1.3 - \<3 ng/m (Ferraretti and Gianaroli, 2014; Calzada et al., 2019) an antral follicle count (AFC) of \>5 on menstrual cycle days 2-3,
  • Exclusion Criteria:
  • History of premature ovulation
  • Azoospermia
  • PCOS
  • Endometriosis AFS ¾
  • Endometrioma
  • Known chromosomal abnormalities

Trial Officials

Barbara Lawrenz, PhD

Study Director

ART Fertility Clinics LLC

About Art Fertility Clinics Llc

Art Fertility Clinics LLC is a leading provider of advanced reproductive healthcare services, specializing in assisted reproductive technologies to support individuals and couples facing fertility challenges. With a commitment to personalized care, state-of-the-art facilities, and a team of experienced specialists, the clinic offers a comprehensive range of services, including in vitro fertilization (IVF), egg freezing, and genetic testing. Art Fertility Clinics LLC is dedicated to advancing reproductive science through innovative clinical trials and research initiatives, ensuring patients receive the most effective and up-to-date treatment options available.

Locations

Abu Dhabi, , United Arab Emirates

Dubai, , United Arab Emirates

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported